SELLAS Life Sciences (SLS) Other Working Capital Changes (2021 - 2026)
SELLAS Life Sciences' (SLS) quarterly Other Working Capital Changes came in at -$159000.0 in Q1 2026, little changed year-on-year from -$159000.0 in Q1 2025, and little changed on a QoQ basis from -$159000.0 in Q4 2025.
SELLAS Life Sciences (SLS) Other Working Capital Changes (2021 - 2026) Analysis & Trends
SELLAS Life Sciences (SLS) has 6 years of Other Working Capital Changes data on file, last reported at -$159000.0 in Q1 2026.
- On a quarterly basis, Other Working Capital Changes changed 0.0% year-over-year to -$159000.0 in Q1 2026; TTM through Mar 2026 was -$635000.0, a 13.39% decrease from a year earlier, with the FY2025 full-year figure at -$635000.0, down 19.14% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$159000.0, roughly flat from -$159000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for SLS reached as high as $2.4 million in Q1 2024 and fell as low as -$1.1 million in Q4 2025.
- Historically, Other Working Capital Changes has averaged $120235.3 across 5 years, with a median of -$340000.0 in 2024.
- On a YoY basis, Other Working Capital Changes climbed as much as 91.6% in 2022 and fell as far as 104.9% in 2022.
- Year by year, Other Working Capital Changes stood at -$127000.0 in 2022, then slipped by 3.94% to -$132000.0 in 2023, then dropped by 2.27% to -$135000.0 in 2024, then dropped by 17.78% to -$159000.0 in 2025, then changed by 0.0% to -$159000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$159000.0 in Q1 2026, -$159000.0 in Q4 2025, and -$158000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | SELLAS Life Sciences | 1.96 Bn | 1.96 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -159,000.00 |
| Mar 31, 2026 | -159,000.00 |
| Mar 31, 2026 | -159,000.00 |
| Dec 31, 2025 | -159,000.00 |
| Dec 31, 2025 | -159,000.00 |
| Dec 31, 2025 | -159,000.00 |
| Sep 30, 2025 | -158,000.00 |
| Sep 30, 2025 | -158,000.00 |
| Sep 30, 2025 | -158,000.00 |
| Jun 30, 2025 | -159,000.00 |
| Jun 30, 2025 | -159,000.00 |
| Jun 30, 2025 | -159,000.00 |
| Mar 31, 2025 | -159,000.00 |
| Mar 31, 2025 | -159,000.00 |
| Mar 31, 2025 | -159,000.00 |
| Dec 31, 2024 | -135,000.00 |
| Dec 31, 2024 | -135,000.00 |
| Dec 31, 2024 | -135,000.00 |
| Sep 30, 2024 | -133,000.00 |
| Sep 30, 2024 | -133,000.00 |